ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 97 | ESPE2023 | Next issue

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sept 2023 - 23 Sept 2023

Card image cap
The 61st ESPE Annual Meeting will now be taking place in The Hague, The Netherlands

Poster Category 1

Growth and Syndromes

Previous section
GH and IGFs
Table of contents
Next section
Multisystem Endocrine Disorders

hrp0097p1-109 | Growth and Syndromes

Unique proteomic signatures of Noonan Syndrome-associated LZTR1 variants detected by phosphopeptide analysis

hrp0097p1-110 | Growth and Syndromes

Comparison of long-term height outcomes in pediatric patients with growth hormone deficiency receiving once weekly somatrogon with those of matched patients treated with once-daily somatropin in the Kabi/Pfizer International Growth Study (KIGS)

hrp0097p1-111 | Growth and Syndromes

The phenotypic spectrum of Kenny-Caffey type 2: a case series and literature review

hrp0097p1-112 | Growth and Syndromes

Treatment of Short Stature in Aggrecan Deficient Patients with Recombinant Human Growth Hormone: Three-Year Growth Response

hrp0097p1-113 | Growth and Syndromes

Etiology of extreme tall stature and auxological cues at presentation

hrp0097p1-114 | Growth and Syndromes

Sex-dimorphic associations of the Prader-Willi imprinted domain with prenatal and postnatal growth in healthy infants

hrp0097p1-115 | Growth and Syndromes

How are gestational age and size at birth related to pubertal timing and adult height? - Results from the GrowUp Gothenburg studies

hrp0097p1-116 | Growth and Syndromes

Phenotypic differences in Noonan syndrome based on PTPN11 mutation status.

hrp0097p1-117 | Growth and Syndromes

Evaluating the Beneficial Role of Nutritional Intervention (NI) Trials in Improving Growth in Children with Beta Thalassemia Major (BTM)

hrp0097p1-118 | Growth and Syndromes

The effect of growth hormone therapy on body composition in girls with Turner syndrome – a 10-year follow-up.

hrp0097p1-119 | Growth and Syndromes

Clinical features and response to rhGH treatment in ten patients with heterozygous IGF1 variants

hrp0097p1-120 | Growth and Syndromes

Personalized behavioral change technique intervention with TUITEK® patient support program to support caregivers of children treated with growth hormone in Korea

hrp0097p1-121 | Growth and Syndromes

First year reponse to growth hormone (GH) therapy is related to long term outcome in GH deficiency (GHD) but not in children born small for gestational age (SGA)

hrp0097p1-122 | Growth and Syndromes

Near Adult Height in a 14-year-old boy with ACAN Deficiency treated with Growth hormone and Anastrozole

hrp0097p1-123 | Growth and Syndromes

Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys

hrp0097p1-124 | Growth and Syndromes

Caloric intake of 6 months-12 years old children with Prader Willi Syndrome under growth hormone treatment at a reference center.

hrp0097p1-125 | Growth and Syndromes

Significant Linear Growth Impairment in a carrier of an interstitial deletion of *356-kb within cytogenetic band 22q11.21 with good response to growth hormone therapy.

hrp0097p1-126 | Growth and Syndromes

A Rare Coexistence of Turner Syndrome and Mycosis Fungoides: A Case Report

hrp0097p1-127 | Growth and Syndromes

Effects and safety of growth hormone (GH) treatment in 6 children with pycnodysostosis

hrp0097p1-128 | Growth and Syndromes

Delayed puberty as a core feature of POLE1: The Irish Experience

hrp0097p1-129 | Growth and Syndromes

Qatar population-specific centile charts of placental weight to birth weight (PW/BW) ratio in 80 722 newborns born between the 37 th and 42 nd Weeks of Gestation: Relation to Gestational Age, and Gender.

hrp0097p1-130 | Growth and Syndromes

The differences of clinical characteristics and effect of growth hormone treatment according to karyotype classification in Turner syndrome patients

hrp0097p1-131 | Growth and Syndromes

Perinatal features of children with Silver-Russell syndrome due to 11p15 loss of methylation

hrp0097p1-132 | Growth and Syndromes

One-year growth response and cost-effectiveness to Human recombinant growth hormone in girls with Turner Syndrome: Results from a large Egyptian retrospective study

hrp0097p1-133 | Growth and Syndromes

A case of Noonan's syndrome and Combined Pituitary Hormone Deficiency: a new potential association?

hrp0097p1-306 | Growth and Syndromes

Annual Hearing Screening in Children with Achondroplasia: Results from the First 4 Years in Glasgow.

hrp0097p1-307 | Growth and Syndromes

A unique combination of Klinefelter syndrome and Three M Syndrome in a boy with short stature

hrp0097p1-308 | Growth and Syndromes

Birth Size and Postnatal Growth in Infants with Solitary Kidney: Does the disease affect Growth?

hrp0097p1-309 | Growth and Syndromes

Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients

hrp0097p1-310 | Growth and Syndromes

Persistence to growth hormone treatment and clinical characteristics of paediatric patients with growth hormone deficiency: A retrospective database study

hrp0097p1-311 | Growth and Syndromes

Management of rhGH treatment in children with CKD in current clinical practice: a multicentric study

hrp0097p1-312 | Growth and Syndromes

Associations between weight-related anthropometric measurements and occurrence of breast development, pubic hair and menarche

hrp0097p1-313 | Growth and Syndromes

Genetic aetiology of short stature in children from consanguineous families from Kurdistan, Iraq

hrp0097p1-314 | Growth and Syndromes

A case report of Noonan-like syndrome and refractory treatment for increasing growth

hrp0097p1-315 | Growth and Syndromes

Which Method is More Effective in Predicting Adult Height in Pubertal Girls Treated with Gonadotropin-Releasing Hormone Agonist?

hrp0097p1-316 | Growth and Syndromes

The effects of androgen treatment on growth in patients with 5-α-Reductase type 2 deficiency

hrp0097p1-317 | Growth and Syndromes

Growth hormone treatment in a case of Melnick-Needles Syndrome

hrp0097p1-318 | Growth and Syndromes

15-year experience with the IGF1 generation test in the Netherlands

hrp0097p1-319 | Growth and Syndromes

Progressively impaired prepubertal growth in children with APECED

hrp0097p1-320 | Growth and Syndromes

Achondroplasia: a novel deep intronic variant of the FGFR3 gene, c.1075 + 95C>G, disrupts mRNA splicing

hrp0097p1-321 | Growth and Syndromes

Questionnaire concerning the process of puberty induction among patients with Turner Syndrome

hrp0097p1-322 | Growth and Syndromes

Postnatal Linear Growth Among Very Low Birthweight Infants (<1.5kg) in the first 2 years of life

hrp0097p1-323 | Growth and Syndromes

A systematic review of core outcomes reported in clinical trials of growth hormone therapy in children with growth hormone deficiency

hrp0097p1-324 | Growth and Syndromes

PROGRES, a multi-country, non-interventional, prospective study of patients receiving human growth hormone treatment under routine clinical care: Study update

hrp0097p1-325 | Growth and Syndromes

Clinical and Genetic Analysis of Ten Short Stature Patients with ACAN Variants

hrp0097p1-326 | Growth and Syndromes

Sex Non-Specific Growth Charts and Potential Clinical Implications in the Care of Transgender Youth and Rare Disease Populations

hrp0097p1-327 | Growth and Syndromes

Growth results after GH treatment of children with juvenile idiopathic arthritis

hrp0097p1-328 | Growth and Syndromes

CEP57 variant associated with MVA2 syndrome in two Moroccan brothers

hrp0097p1-329 | Growth and Syndromes

Long-term (9-year, 8-year and 3.5-year) follow-up of treatment with rhGH in three patients with Noonan syndrome due to PTPN11 mutation and confirmed growth hormone deficiency.

hrp0097p1-330 | Growth and Syndromes

A complex phenotype due to the overlap of two rare conditions: miller-mckusick-malvaux (3M) and chung-jansen syndrome

hrp0097p1-505 | Growth and Syndromes

Changes in carbohydrate and lipid metabolism during 10-year follow-up of patients with Turner syndrome treated with growth hormone.

hrp0097p1-506 | Growth and Syndromes

Characteristics, effectiveness and safety data for patients with growth failure treated with recombinant IGF-1 and achieving adult or near-adult height: results from the Increlex® Global Registry

hrp0097p1-507 | Growth and Syndromes

Identification and characterisation of novel HMGA2 variants expand the clinical spectrum of Silver-Russell syndrome

hrp0097p1-508 | Growth and Syndromes

Placental measurements in relation to gestational age (GA) and fetal growth Characteristics (SGA, AGA and LGA) in a large Cohort in Qatar(n= 80722).

hrp0097p1-509 | Growth and Syndromes

Significant height response to growth hormone treatment in subjects with Wiedemann Steinert syndrome.

hrp0097p1-510 | Growth and Syndromes

Tuberous sclerosis complex 1 (TSC1) deficiency leads to increased proliferation of adipose progenitor cells – case report and in vitro studies

hrp0097p1-511 | Growth and Syndromes

Pathway to assess severe primary IGF-1 deficiency diagnosis by using the IGF-1 generation test in a real-life setting: data from the Global Increlex® Registry

hrp0097p1-512 | Growth and Syndromes

Growth and final height of adolescents with systemic juvenile idiopathic arthritis in the transitional age: a monocentric case series

hrp0097p1-513 | Growth and Syndromes

Efficacy of Once-Weekly Treatment for Paediatric Growth Hormone Deficiency: A Systematic Literature Review and Indirect Treatment Comparison

hrp0097p1-514 | Growth and Syndromes

Addition of genetic workup in children with isolated short stature to improve the diagnostic yield for growth hormone treatment

hrp0097p1-515 | Growth and Syndromes

Two novel cases of CHOPS syndrome support the evidence of a highly homogeneous phenotype including short stature with skeletal abnormalities and obesity

hrp0097p1-516 | Growth and Syndromes

Analysis of Pubertal Height Gain after Menarchal girls in Korea

hrp0097p1-517 | Growth and Syndromes

Bridging the gap between short stature and metabolic alterations in children born small for gestational age: an exploratory study

hrp0097p1-518 | Growth and Syndromes

Outcomes of growth hormone treatment in children with Prader Willi Syndrome over a 30-year period at the Children’s Hospital at Westmead, New South Wales Australia

hrp0097p1-519 | Growth and Syndromes

Evaluation of Cognitive Profiles in a cohort of patients with Turner Syndrome.

hrp0097p1-520 | Growth and Syndromes

Does cervical medullary decompression have an impact on growth in children with achondroplasia?

hrp0097p1-521 | Growth and Syndromes

A variant of uncertain significance in HMGA2 gene, in a 2-year-old child with Silver Russel syndrome like phenotype - a case report

hrp0097p1-522 | Growth and Syndromes

ACAN gene mutation in a patient born small for gestational age with familial short stature

hrp0097p1-523 | Growth and Syndromes

A rare occurrence of non-classic congenital adrenal hyperplasia and type 1 diabetes mellitus in a girl with Prader-Willi Syndrome: Case report and review of the literature

hrp0097p1-524 | Growth and Syndromes

Two male siblings with extremely tall stature, moderate mental retardation and a deletion of ASH1L at chromosome 1q22.

hrp0097p1-525 | Growth and Syndromes

Human milk insulin-like growth factor-1 (HMIGF1) and its effects on Infantile and Childhood Growth

hrp0097p1-526 | Growth and Syndromes

The first description of neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome)in the Russian Federation.

hrp0097p1-527 | Growth and Syndromes

Application of next-generation sequencing in patients suspected of having skeletal dysplasia

hrp0097p1-528 | Growth and Syndromes

Seasonality in growth of preschool children in Palestine, a pilot study

hrp0097p1-529 | Growth and Syndromes

A Rare Cause of Pathological Tall Stature: Luscan Lumish Syndrome

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more